Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegvisomant and Sandostatin LAR in Acromegaly
NCT00068029Phase 4Completed
- Sponsor
- Pfizer
- Start
- Oct 2003
- Countries
- 12
01
Overview
Phase 4, randomised, open-label trial of pegvisomant in acromegaly, sponsored by Pfizer. Started Oct 2003; status: completed.
02
Drugs
pegvisomant
03
Conditions
acromegaly
Beyond the preview
Go deeper on NCT00068029.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00068029.